Dna Testing Centers (DNAT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DNAT Annual Balance Sheets →
The balance sheet data below highlights changes in Dna Testing Centers's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2018)
(Dec 31 2017) (Sep 30 2017) (Jun 30 2017) (Mar 31 2017)
Assets
Cash & cash equivalent0.05
Cash & Short-term Investments0.00
Accounts receivable0.00
Prepaid Expense, Current AS0.00
Total Current Assets0.05
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.00
Total Assets0.05
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.04
Other Liabilities, Current0.00
Total Current Liabilities0.04
Total Long-term Debt0.00
Other liabilities, Noncurrent0.15
Total Liabilities0.19
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock0.21
Retained Earnings / Accumulated Deficit-0.43
Other Equity-0.01
Common Stockholder's Equity-0.14
Total Stockholder's Equity-0.14
Liabilities & Stockholder's Equity0.05
4 historic quarters locked

Sign in to unlock the full Dna Testing Centers balance sheet history.

About DNAT Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.